Logo-jcvtr

J Cardiovasc Thorac Res. 2016;8(4): 152-157. doi: 10.15171/jcvtr.2016.31
PMID: 28210470        PMCID: PMC5304097

Original Article

Risk factor control, adherence to medication and follow up visit, five years after coronary artery bypass graft surgery

Arsalan Salari 1, Tolou Hasandokht 1,2 * , Marjan Mahdavi-Roshan 1,2, Jalal Kheirkhah 1, Mahboueh Gholipour 1, Mahsa Pouradollah Tootkaoni 1

Cited by CrossRef: 1


1- Paquette M, França L, Teutsch C, Diener H, Lu S, Dubner S, Ma C, Rothman K, Zint K, Halperin J, Olshansky B, Huisman M, Lip G, Nieuwlaat R. Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry. The American Journal of Cardiology. 2020;125(3):383 [Crossref]
2- Arslantürk O, Aydın A, Gümüş F, Aydın K, Zeybek D, Canpınar H, Güvener M. Unraveling the Mystery: How High Density Lipoprotein ‘Good’ Cholesterol Goes ‘Bad’?. Med J West Black Sea. 2024;8(2):177 [Crossref]